Tokyo, April 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061199) titled 'A study investigating the clinical course of bronchiectasis after treatment for nontuberculous mycobacterial pulmonary disease' on April 8.
Study Type:
Observational
Primary Sponsor:
Institute - Japan Anti-Tuberculosis Association, Fukujuji Hospital
Condition:
Condition - Bronchiectasis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the clinical course and characteristivs of bronchiectasis after treatment for nontuberculous mycobacterial pulmonary disease.
Basic objectives2 - Bio-equivalence
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients who received treatment for nontuberculous mycobacterial pulmonary disease at Fukujuji Hospital between January 2006 and Novemnber 2019, achieved microbiological cure, and completed treatment.
Key exclusion criteria - HIV positive
Patients without bronchiectasis
Target Size - 400
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2024 Year 10 Month 01 Day
Date of IRB - 2024 Year 12 Month 12 Day
Anticipated trial start date - 2024 Year 12 Month 13 Day
Last follow-up date - 2026 Year 09 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070012
Disclaimer: Curated by HT Syndication.
